How many days does it take for Wegovy to start working?

Appetite suppression can appear within days of the first injection, but most people notice it clearly in week one or two.
The titration schedule (starting at 0.25mg and increasing every four weeks) means your body adjusts steadily; the therapeutic effect builds with each step up.
Trial data shows the largest proportion of total weight loss occurs between weeks 12 and 48 of treatment, not in the opening days.
Side effects, especially nausea, are typically most noticeable straight after starting or after a dose increase, and they often settle within one to two weeks.

Most people notice Wegovy beginning to reduce their appetite within the first week or two of starting, though meaningful weight loss typically becomes visible over several weeks rather than days. The STEP 1 trial, published in the New England Journal of Medicine, found participants on semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks — a result built up gradually, not overnight. Wegovy (semaglutide) is a prescription-only medicine, and a clinician assesses whether it is suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence actually shows about Wegovy's timeline — and what to expect week by week

What happens in the first few days: appetite before the scales move

The first thing most people on Wegovy report is a quietening of hunger signals, often within three to five days of the initial injection. Semaglutide acts on GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing the drive to eat. That effect starts from dose one. What it does not do, at least not immediately, is move the number on the scales by any meaningful amount. In those opening days the body is simply adjusting to the medicine's presence.

Nausea is common early on and tends to peak in the first week or so after each new dose, then ease. This is partly why the licensed schedule begins at 0.25mg, a level chosen for tolerability, giving your system time to settle before the dose climbs. You can read more about preparing for that adjustment period in our guide on how to prepare for Wegovy.

The practical upshot: if you inject on a Monday and feel no different by Thursday, that is normal. The question of how many days Wegovy takes to work depends partly on which effect you mean, appetite, weight, or both.

Weeks one to twelve: when early weight loss usually appears

By weeks four to eight, most people who tolerate Wegovy well have moved up at least one dose tier and are starting to see measurable weight change. The NHS medicines page for semaglutide notes that treatment is assessed at six months, if less than 5% of starting weight has been lost by that point on the maintenance dose, continuing is reviewed. That six-month checkpoint is built into the clinical pathway precisely because results accumulate across months, not days.

Early weight loss in the first four weeks tends to be modest, often two to four pounds on average in trials. It accelerates as the dose increases and appetite suppression becomes more pronounced. If you have ever wondered whether your injection day matters, our page on what time of day is best for Wegovy covers the practicalities without overcomplicating them.

One thing worth noting: people who start treatment mid-week, or just before a bank holiday, sometimes feel the first week drags longer than it does. In reality the biology does not care whether it is payday or a Monday morning, the timeline is governed by pharmacology, not the calendar.

Months three to twelve: where most of the work happens

The STEP 1 trial data is clear that the steepest part of the weight-loss curve runs from roughly week 12 through to week 44 or so, before beginning to plateau. Average loss at 68 weeks was around 15% of body weight on the 2.4mg maintenance dose. More recently, the MHRA approved a higher 7.2mg dose, with trial data showing approximately 20.7% average loss over 72 weeks at that level, narrowing the gap with tirzepatide results considerably. Details on how Wegovy's evidence compares with other options are on our Wegovy vs Ozempic page and in the direct semaglutide comparison.

The practical message is that Wegovy is not a medicine whose results arrive in days. The first days bring appetite change; the first months bring measurable weight change; the full effect takes the better part of a year. That is consistent with how NICE frames it in its recommendation for semaglutide (TA875), which sets a six-month review point rather than a six-week one.

What slows the process, and whether switching to a different medicine makes sense

A few things can blunt or delay the expected response. Dose increases that happen more slowly than the four-weekly schedule (sometimes because side effects need more time to settle) push the timeline out. Illness or a period of higher stress may temporarily stall progress. And a small proportion of people on semaglutide find their response plateaus earlier than average, which is one reason tirzepatide (a dual GIP and GLP-1 receptor agonist) is sometimes considered instead. Our overview of Wegovy covers the full licensed picture, and if you are thinking about cost as part of your decision, the Wegovy price guide explains what a legitimate private prescription typically includes.

People transferring from another injectable, such as liraglutide, sometimes find the adjustment to semaglutide's rhythm feels different, if that applies to you, the guide on switching from Saxenda to Wegovy walks through what to expect. The broader question of how weeks, not just days, shape the outcome is covered in our piece on how many weeks Wegovy takes to work.

None of this replaces the conversation with a prescriber, who can assess your individual picture. If Wegovy looks right for your situation, check your eligibility with our clinical team, consultations are free, reviewed the same day by a GPhC-registered prescriber, and there are no subscriptions or hidden fees.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions